Ultragenyx Pharmaceutical | RARE - Trade Creditors



Ultragenyx Pharmaceutical reported $34.24M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
Agios Pharmaceuticals USD 17.53M 3.81M Jun/2025
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Insmed USD 78.35M 16.95M Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
Kyowa Hakko Kirin JPY 108.73B 10.35B Jun/2025
MacroGenics USD 4.66M 353K Jun/2025
Moderna USD 175M 51M Jun/2025
Neurocrine Biosciences 104.6M 5.4M Jun/2025
PTC Therapeutics USD 206.31M 191.16M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025